Aroa Biosurgery Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was NZD 69.07 million compared to NZD 63.36 million a year ago. Net loss was NZD 10.63 million compared to NZD 0.396 million a year ago.

Basic loss per share from continuing operations was NZD 0.0309 compared to NZD 0.0012 a year ago. Diluted loss per share from continuing operations was NZD 0.0309 compared to NZD 0.0012 a year ago.